Company intelligence
Allotex
Natural, tissue-based solutions for refractive surgery
Medical Device
Boston, US
30 employees
6 public signals
About Allotex
Allotex develops natural, tissue-based solutions for refractive surgery. Precision-shaped collagen implants are designed to integrate naturally with the eye, enabling safe additive procedures that fit seamlessly into modern surgical workflows, with proven clinical outcomes.
Verified activity
Signals from Allotex
6 published signals
Research & Knowledge
Allotex presented reversibility of Stromal Allograft Corneal Inlays long-term outcomes after explantation at the ESCRS iNOVATION DAY on 14 September.
Reported by Allotex
Research & Knowledge
Allotex presented long-term results of presbyopic allogeneic corneal inlay implantation compared between the implanted eye, fellow eye, and changes in binocular visual acuity at the ESCRS iNOVATION DAY on 14 September.
Reported by Allotex
Research & Knowledge
Allotex presented initial clinical results of presbyopia correction using allograft corneal inlays in conjunction with LASIK at the ESCRS iNOVATION DAY on 11 September.
Reported by Allotex
Presence & Recognition
Allotex is exhibiting at the ESCRS meeting with the Allotex team and surgeons during the Meet the Experts sessions.
Reported by Allotex
Products & Services
Allotex announced that TransForm™ is available for clinical use outside the United States and is not available for distribution in the United States.
Reported by Allotex
Presence & Recognition
Allotex is hosting a practical conversation with two surgeons using TransForm™ in clinical practice at ESCRS 2026 at Allotex Booth E.314 on Sept. 12, 11:00–11:30 and 13:00–13:30.
Reported by Allotex